We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against ...

Oppo India introduces a sky blue variant of the Reno 13 series for the Holi festival, available from March 20. Priced at Rs 43,999 the new colour variant comes in a 12GB RAM with 512GB storage option.

Apple today announced refreshed 13- and 15-inch MacBook Air models, now featuring the M4 chip, an upgraded camera, and a new "Sky Blue" color option. "Sky Blue" is an all-new blue finish that ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

Merck licenses the protein, called berahyaluronidase alfa, from Alteogen. Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents.

So my students are often surprised when I tell them that St. Patrick’s Day was once a solemn feast day when you’d be far more likely to see the color blue. In fact, there’s even a color ...

Apple is also adding a new color option for the first time in a while, a Sky Blue color reminiscent of (but a little less saturated than) the Sapphire blue color that Microsoft uses for Surface PCs.

March 11 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid ...

A new patent dispute is brewing between Halozyme Therapeutics (NASDAQ:HALO), a biotech focused on drug delivery technology, and Merck (NYSE:MRK) over an injectable version of the New Jersey-based ...

Don't be surprised the next time you order from economy rice stalls in Koufu food courts and coffee shops — they will soon feature colour-coded ... will be labelled blue, meat dishes red ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.

March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...